Usefulness of Acupuncture in Cancer Pain and Quality of Life

Acupuncture Case Series: Cancer Pain and Quality of Life

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00401063

Enrollment

Registered

2006-11-17

Start date

2006-09-30

Completion date

2007-10-31

Last updated

2013-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Pain

Keywords

Cancer, Acupuncture, Cancer Pain, Quality of life

Brief summary

The purpose of this study is to assess the effects of acupuncture on aspects of health including pain, energy level, sleep quality, activities of daily living and appetite.

Detailed description

After receiving permission from the attending physician each study participant who meets the inclusion criteria will then undergo a physical examination and fill out several questionnaires. Each participant will undergo one to three treatments per week for a period of eight weeks. There will be one follow-up visit on the twelfth week. Participation in this study is free of charge, including all exams, treatment and informational material.

Interventions

DEVICEAcupuncture

Acupuncture treatment twice a day for eight weeks

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Confirmed diagnosis of cancer by an MD/oncologist * Age of 18 or older * Baseline pain score of 3 or above on 0-10 rating scale * In the evaluation of the treating physician or medically-qualified investigator, the patient's pain syndrome is the result of underlying cancer or cancer treatment * Being ambulatory * Permission from the treating physician (MD/oncologist) * Platelet count of 50,000 or greater

Exclusion criteria

* Acupuncture treatment in past four weeks * Neutropenia defined as ANC (absolute neutrophil count) \< 1000/ml * Inability to obtain permission from the treating physician * Unwillingness to sign informed consent form * Involvement in litigation * Simultaneous infection with HIV or Hepatitis C virus * Unable to present for follow up

Design outcomes

Primary

Measure	Time frame
EORTC QLQ-30 Quality of Life Questionnaire for Cancer Patients	Every two weeks, 0, 2, 4, 6, 8 and 12
Visual Analogue Scale	Every two weeks, 0,2,4,6,8, and 12 weeks

Secondary

Measure	Time frame
BDI Psychological Assessment	Every two weeks, 0, 2, 4, 6, 8 and 12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026